These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 23843589)

  • 1. The HONEYPOT randomized controlled trial statistical analysis plan.
    Pascoe EM; Lo S; Scaria A; Badve SV; Beller EM; Cass A; Hawley CM; Johnson DW
    Perit Dial Int; 2013; 33(4):426-35. PubMed ID: 23843589
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The honeypot study protocol: a randomized controlled trial of exit-site application of medihoney antibacterial wound gel for the prevention of catheter-associated infections in peritoneal dialysis patients.
    Johnson DW; Clark C; Isbel NM; Hawley CM; Beller E; Cass A; de Zoysa J; McTaggart S; Playford G; Rosser B; Thompson C; Snelling P;
    Perit Dial Int; 2009; 29(3):303-9. PubMed ID: 19458303
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Exit-Site Antibacterial Honey Versus Nasal Mupirocin Prophylaxis on the Microbiology and Outcomes of Peritoneal Dialysis-Associated Peritonitis and Exit-Site Infections: A Sub-Study of the Honeypot Trial.
    Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2015 Dec; 35(7):712-21. PubMed ID: 26224790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of preventing Staphylococcus aureus carriage on rates of peritoneal catheter-related staphylococcal infections. Literature synthesis.
    Ritzau J; Hoffman RM; Tzamaloukas AH
    Perit Dial Int; 2001; 21(5):471-9. PubMed ID: 11757831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibacterial honey for the prevention of peritoneal-dialysis-related infections (HONEYPOT): a randomised trial.
    Johnson DW; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; McTaggart S; Morrish AT; Playford EG; Scaria A; Snelling P; Vergara LA; Hawley CM;
    Lancet Infect Dis; 2014 Jan; 14(1):23-30. PubMed ID: 24119840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical Honey in the Management of Pediatric Peritoneal Dialysis Exit Sites.
    Forbes TA; Shaw L; Quinlan C
    Perit Dial Int; 2016 11-12; 36(6):684-687. PubMed ID: 27903852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Representativeness of Honeypot Trial Participants to Australasian PD Patients.
    ; Zhang L; Badve SV; Pascoe EM; Beller E; Cass A; Clark C; de Zoysa J; Isbel NM; Liu X; McTaggart S; Morrish AT; Playford G; Scaria A; Snelling P; Vergara LA; Hawley CM; Johnson DW;
    Perit Dial Int; 2017; 37(5):516-522. PubMed ID: 27935534
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin.
    Bernardini J; Piraino B; Holley J; Johnston JR; Lutes R
    Am J Kidney Dis; 1996 May; 27(5):695-700. PubMed ID: 8629630
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An integrated critique of the efficacy of topical mupirocin in preventing catheter-related Staphylococcus aureus infections in peritoneal dialysis clients.
    Pratt O
    CANNT J; 2002; 12(1):20-8. PubMed ID: 11979650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Outcome and clinical implications of a surveillance and treatment program for Staphylococcus aureus nasal carriage in peritoneal dialysis patients.
    Crabtree JH; Hadnott LL; Burchette RJ; Siddiqi RA
    Adv Perit Dial; 2000; 16():271-5. PubMed ID: 11045309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of Topical Chlorhexidine and Mupirocin for the Prevention of Exit-Site Infection in Incident Peritoneal Dialysis Patients.
    Htay H; Johnson DW; Wu SY; Oei EL; Foo MWY; Choo JCJ
    Perit Dial Int; 2017; 37(3):266-272. PubMed ID: 28183858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term Staphylococcus aureus decolonization in patients on home parenteral nutrition: study protocol for a randomized multicenter trial.
    Gompelman M; Wouters Y; Kievit W; Hopman J; Wertheim HF; Bleeker-Rovers CP; Wanten GJA
    Trials; 2018 Jun; 19(1):346. PubMed ID: 29954418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomized controlled trial comparing mupirocin versus Polysporin Triple for the prevention of catheter-related infections in peritoneal dialysis patients (the MP3 study).
    Jassal SV; Lok CE;
    Perit Dial Int; 2008; 28(1):67-72. PubMed ID: 18178950
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of a silver device in preventing catheter-related infections in peritoneal dialysis patients: silver ring prophylaxis at the catheter exit study.
    Pommer W; Brauner M; Westphale HJ; Brunkhorst R; Krämer R; Bundschu D; Höffken B; Steinhauer HB; Schümann E; Lüttgen FM; Schillinger-Pokorny E; Schaefer F; Wende R; Offner G; Näther S; Osten B; Zimmering M; Ehrich JH; Kehn M; Mansmann U; Grosse-Siestrup C
    Am J Kidney Dis; 1998 Nov; 32(5):752-60. PubMed ID: 9820444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antimicrobial agents for preventing peritonitis in peritoneal dialysis patients.
    Campbell D; Mudge DW; Craig JC; Johnson DW; Tong A; Strippoli GF
    Cochrane Database Syst Rev; 2017 Apr; 4(4):CD004679. PubMed ID: 28390069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effectiveness of mupirocin preventing Staphylococcus aureus in catheter-related infections in peritoneal dialysis.
    Thodis E; Passadakis P; Panagoutsos S; Bacharaki D; Euthimiadou A; Vargemezis V
    Adv Perit Dial; 2000; 16():257-61. PubMed ID: 11045306
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternating Mupirocin/Gentamicin is Associated with Increased Risk of Fungal Peritonitis as Compared with Gentamicin Alone - Results of a Randomized Open-Label Controlled Trial.
    Wong PN; Tong GM; Wong YY; Lo KY; Chan SF; Lo MW; Lo KC; Ho LY; Tse CW; Mak SK; Wong AK
    Perit Dial Int; 2016; 36(3):340-6. PubMed ID: 27044796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of nasal carriage of Staphylococcus aureus--is it cost-effective?
    Davey P
    J Hosp Infect; 1998 Sep; 40 Suppl B():S31-7. PubMed ID: 9777531
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical Value of Screening Peritoneal Dialysis Patients for Bacterial Colonization or Contamination.
    Parthasarathy R; Kashem T; NicFhogartaigh C; Melzer M; Fan SL
    Perit Dial Int; 2019; 39(2):126-133. PubMed ID: 30739095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of correlation between nasal cultures positive for Staphylococcus aureus and the development of S. aureus exit-site infections: results unaffected by routine mupirocin treatment of nasal S. aureus carriage.
    Hanslik TM; Newman L; Tessman M; Morrissey AB; Friedlander MA
    Adv Perit Dial; 1994; 10():158-62. PubMed ID: 7999817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.